Delivery Order SPE2DB20D2104-SPE2DB23FT05J

Award Date 4/12/23
Potential Completion Date 4/13/23
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,337.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,213,468 units of Cetirizine HCL 5 mg tablets in 100-count bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,967.72 firm-fixed-price contract is for the delivery of 4,567,520,514 units of Cetirizine HCl 5 mg tablets to support military healthcare programs. The contract has a period of performance through March 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a $17,377.06 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,910,880 units of Cetirizine HCL 5 mg tablets, and has a completion date of November 28, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,907.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,881,452 units of cetirizine HCL 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine HCL 10 mg tablets. The contract has a firm fixed price, with a ceiling value of $57,426.15, and runs through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,726.63, is for the delivery of 4,567,410,467 units of Cetirizine HCL 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 28, 2025. The contract was awarded on February 27, 2025 and does not have a set-aside designation. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.71, is a Delivery Order for the supply of 4,566,731,869 units of Cetirizine HCL 10 mg Tablets in 100-count packages. The contract has a period of performance through December 17, 2024, with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,158.96 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through February 2024, is for the supply of 4,563,713,933 units of Cetirizine HCl 10 mg tablets. This award is part of a larger $999,999,999 IDC between Amerisourcebergen and the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,796.22 firm fixed-price delivery order covers the supply of 4,567,238,274 units of Cetirizine HCl 5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,971.07 firm fixed-price delivery order is for 4,564,793,676 units of the drug Cetirizine HCL 5 mg Tablets. The contract has a completion date of June 4, 2024 and was awarded on June 3, 2024. No set-aside designations were used for this award. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FT05J
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,567,379 units of 10 mg Cetirizine HCL tablets. The $13,146.34 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical supply products in support of military healthcare programs globally. The contract does not have any set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate AmerisourceBergen's role as a key vendor for federal healthcare procurement, with a focus on supporting the medical needs of military personnel, veterans, and other government beneficiaries.

Generated 2/27/25, 12:11 PM